Status:
UNKNOWN
Stress Reduction and Lifestyle Modification in Irritable Bowel Syndrome Patients
Lead Sponsor:
Universität Duisburg-Essen
Collaborating Sponsors:
Bavarian State Ministry of Health and Care
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In the planned efficacy study, a prospective randomized controlled trial will be conducted to investigate the extent to which a multimodal stress reduction and lifestyle modification program can be re...
Detailed Description
The intervention is a 10-week multimodal stress reduction and lifestyle modification program consisting of 10 sessions, each lasting 6 hours. In groups of around 10 individuals, patients are comprehen...
Eligibility Criteria
Inclusion
- confirmed diagnosis of irritable bowel syndrome (IBS with diarrhea, IBS with constipation, mixed-type IBS, or unspecified IBS); IBS-SSS Score \> 75
Exclusion
- Severe mental illness (e.g., clinically significant depression, substance use disorder, schizophrenia)
- Severe comorbid somatic illness (e.g., oncological disease)
- Pregnancy
- Participation in other stress reduction programs or clinical studies on psychological interventions
- Known intolerances (fructose, lactose), celiac disease, etc.
Key Trial Info
Start Date :
November 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT06145022
Start Date
November 10 2023
End Date
July 31 2025
Last Update
November 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sozialstiftung Bamberg
Bamberg, Bavaria, Germany, 96049